Launxp Biomedical Co (ROCO:6876) FCF Margin %: 0.00% (As of Dec. 2025)


ROCO:6876 Launxp Biomedical Co Ltd ROCO:6876
11 GF Score
Price NT$15.90
! 4 Warning Signs
View Full Analysis

What is Launxp Biomedical Co FCF Margin %?

Launxp Biomedical Co ROCO:6876 -0.93% 11 FCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates ROCO:6876 with a GF Score™ of 11/100. The stock has 4 warning signs investors should review. Among 958 Biotechnology companies, Launxp Biomedical Co ranks worse than 104384.03% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Launxp Biomedical Co's Free Cash Flow for the six months ended in Dec. 2025 was NT$-209.91 Mil. Launxp Biomedical Co's Revenue for the six months ended in Dec. 2025 was NT$0.00 Mil. Therefore, Launxp Biomedical Co's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Launxp Biomedical Co's current FCF Yield % is -26.27%.

The historical rank and industry rank for Launxp Biomedical Co's FCF Margin % or its related term are showing as below:


During the past 6 years, the highest FCF Margin % of Launxp Biomedical Co was -3098.79%. The lowest was -567745.45%. And the median was -3352.75%.

ROCO:6876's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -85.21
* Ranked among companies with meaningful FCF Margin % only.

Launxp Biomedical Co FCF Margin % Related Terms

Launxp Biomedical Co FCF Margin % Historical Data

* Premium members only.

The historical data trend for Launxp Biomedical Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Launxp Biomedical Co FCF Margin % Chart

Launxp Biomedical Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial 0.00 0.00 -567,745.45 -3,098.79 0.00

Launxp Biomedical Co Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -280,545.45 -1,559.74 0.00 0.00 0.00

ROCO:6876 vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Launxp Biomedical Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Launxp Biomedical Co FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Launxp Biomedical Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Launxp Biomedical Co's FCF Margin % falls into.


ROCO:6876
11GF Score
Launxp Biomedical Co Ltd ROCO:6876
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Launxp Biomedical Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Launxp Biomedical Co's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-295.313/0
= %

Launxp Biomedical Co's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-209.912/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Launxp Biomedical Co (ROCO:6876) has a FCF Margin % of 0.00% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Launxp Biomedical Co and its competitors. According to the industry distribution chart, Launxp Biomedical Co ranks #999999 out of 958 companies in the Biotechnology industry.
Is Launxp Biomedical Co's FCF Margin % too high?
Launxp Biomedical Co's current FCF Margin % is 0.00%. Based on the distribution chart, Launxp Biomedical Co ranks #999999 out of 958 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Launxp Biomedical Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Launxp Biomedical Co's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Launxp Biomedical Co ranks #999999 out of 958 companies for FCF Margin %. This places Launxp Biomedical Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Launxp Biomedical Co and its competitors. Launxp Biomedical Co's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Launxp Biomedical Co stock overvalued right now?
Launxp Biomedical Co (ROCO:6876) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Launxp Biomedical Co's overall GF Score™ is 11/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Launxp Biomedical Co (ROCO:6876), the current FCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Launxp Biomedical Co Business Description

Address 10F, No. 51, Section 2, Gongyi Road, Nantun District, Taichung, TWN, 408
Launxp Biomedical Co Ltd is a company that researches, designs and develops Cancer drug rapid screening platform and Early development evaluation and technology licensing of generic drugs for cancer treatment. The company mainly focuses on the screening of development drugs, formulation of development strategies, project management, planning and execution of regulations and clinical trials, etc.
11GF Score

Get the complete analysis for ROCO:6876

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$15.90
Price